This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

About Diabetes » Control

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Diabetes Patients Risk for Death Greatly Increases with Kidney Damage

Posted: Sunday, February 26, 2012

Control of blood sugar and catching early signs of damage may help prevent advanced kidney disease and death.

Resistance Training Improves Outcomes in Type 2 Diabetes

Posted: Sunday, February 26, 2012

Besides improving patients' glucose numbers researchers saw improved metabolic features such as reductions in waist circumference.

Setting Goals Improves Dietary Habits of Diabetes Patients

Posted: Friday, February 17, 2012

A specific goal to eat a set number of daily servings of low-glycemic-index foods can improve dietary habits of people with type 2 diabetes.

Intermittent Exercise Improves Glucose for People with Diabetes

Posted: Monday, February 13, 2012

New study finds exercise in low oxygen environment may result in improved insulin sensitivity.

New ACP Guidelines for Type 2 Diabetes Treatment

Posted: Sunday, February 12, 2012

Metformin should be the initial drug for most patients with type 2 diabetes refractory to lifestyle modifications, with a second drug added if needed, according to a new clinical practice guideline from the ACP.

Efficacy and Safety of Bydureon Versus Metformin, Pioglitazone, and Sitagliptin as Monotherapy

Posted: Monday, February 06, 2012

In a once weekly injection of exenatide for Drug-Naive Patients with Type 2 Diabetes (DURATION-4) in a 26-week double-blind study they found that exenatide once weekly (EQW) was noninferior to metformin (MET) but not pioglitazone (PIO) and superior to sitagliptin (SITA) with regard to HbA1c reduction at 26 weeks.

Gene Study Sheds Light on Body Clock's Link to Diabetes

Posted: Monday, February 06, 2012

A mutation affecting a sleep-wake hormone may disrupt blood sugar control.

FDA Approves BYDUREON™ -- The First Once-Weekly Treatment for Type 2 Diabetes

Posted: Sunday, January 29, 2012

Once weekly Bydureon will be available in February at the approximate coast of $323 dollars a month which will include 4 injection syringes using 1 per week.

Intranasal Insulin Boosts Cognitive Function

Posted: Saturday, January 28, 2012

Pooled data suggest that intranasal insulin may have a positive effect on cognition in both impaired and normal subjects.

New NIH fact sheet explains test for diabetes, prediabetes

Posted: Thursday, January 26, 2012

A new fact sheet from the National Institutes of Health explains the A1C test, a widely used and important test to diagnose type 2 diabetes and prediabetes, and to monitor blood glucose levels of people with type 1 and type 2 diabetes.